Biomark Diagnostics (Biomark Diagnostics) Additional Paid-In Capital : $1.73 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics Additional Paid-In Capital?

Biomark Diagnostics's quarterly additional paid-in capital declined from Jun. 2023 ($1.71 Mil) to Sep. 2023 ($1.70 Mil) but then increased from Sep. 2023 ($1.70 Mil) to Dec. 2023 ($1.73 Mil).

Biomark Diagnostics's annual additional paid-in capital increased from Mar. 2021 ($1.30 Mil) to Mar. 2022 ($1.34 Mil) and increased from Mar. 2022 ($1.34 Mil) to Mar. 2023 ($1.63 Mil).

Biomark Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for Biomark Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Additional Paid-In Capital Chart

Biomark Diagnostics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

0.61

1.27

1.30

1.34

1.63

Biomark Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															1.64	1.63	1.71	1.70	1.73

Biomark Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Biomark Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics (Biomark Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (Biomark Diagnostics) Headlines

No Headlines